Last reviewed · How we verify
Silvadene® Cream 1% [Silver Sulfadiazine]
Silvadene® Cream 1% [Silver Sulfadiazine] is a Small molecule drug developed by Skingenix, Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | Silvadene® Cream 1% [Silver Sulfadiazine] |
|---|---|
| Sponsor | Skingenix, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Silvadene® Cream 1% [Silver Sulfadiazine] CI brief — competitive landscape report
- Silvadene® Cream 1% [Silver Sulfadiazine] updates RSS · CI watch RSS
- Skingenix, Inc. portfolio CI
Frequently asked questions about Silvadene® Cream 1% [Silver Sulfadiazine]
What is Silvadene® Cream 1% [Silver Sulfadiazine]?
Silvadene® Cream 1% [Silver Sulfadiazine] is a Small molecule drug developed by Skingenix, Inc..
Who makes Silvadene® Cream 1% [Silver Sulfadiazine]?
Silvadene® Cream 1% [Silver Sulfadiazine] is developed by Skingenix, Inc. (see full Skingenix, Inc. pipeline at /company/skingenix-inc).
What development phase is Silvadene® Cream 1% [Silver Sulfadiazine] in?
Silvadene® Cream 1% [Silver Sulfadiazine] is in Phase 2.